-+ 0.00%
-+ 0.00%
-+ 0.00%

LongBio Pharma names Xue Kailu as non-executive director, replacing Chen Kan

PUBT·08/21/2026 14:15:43
Listen to the news
LongBio Pharma names Xue Kailu as non-executive director, replacing Chen Kan
  • LongBio Pharma (Suzhou) set a non-executive director change, with Chen Kan to step down effective Aug. 31, 2026.
  • Shareholders will vote at an extraordinary general meeting on appointing Xue Kailu as a non-executive director.
  • Xue has 17 years in biological analysis, including project manager roles at WuXi AppTec units.
  • He has served as deputy general manager at Caresun Pharmaceutical since August 2018.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longbio Pharma (Suzhou) Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260821-12295162), on August 21, 2026, and is solely responsible for the information contained therein.